glp 1 drugs and vision loss GLP-1 linked to rare loss: JAMA study | Pharmavoice.in posted on the topic Danny D. | 👁️ Important

Intestinal alteration of -gustducin and sweet taste signaling pathway in metabolic diseases is partly rescued after weight loss and diabetes remission

In the T2D study, HbA1c improved by 2.2%, with 82% of participants reaching HbA1c 6.5%

Gier et al (38) reported PanIN lesions located primarily in pancreatic duct glands of normal rats treated with exendin-4

Endocrinologists began prescribing these medications to millions of patients worldwide seeking better metabolic control

doi: 10.1111/cup.12246

Eligibility criteria We used the Population, Intervention, Comparison, and Outcomes (PICO) criteria to select eligible randomized controlled trials and observational studies: population (patients diagnosed with idiopathic intracranial hypertension, aged 18 years)